热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse Ly-6C Antibody
产品名称：
Purified anti-mouse Ly-6C Antibody
产品类别：
抗体
产品编号：
128001
产品应用：
128001
[价格]
规格 价格 库存
50µg ￥ 780 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume or 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  3. Filippini D, et al. 2019. Sci Rep. 9:12286. PubMed
  4. Baja?a S, et al. 2021. Front Immunol. 11:577718. PubMed
  5. Nobs SP, et al. 2021. J Allergy Clin Immunol. . PubMed
  6. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  7. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  8. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  9. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  10. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  11. Orecchioni M, et al. 2022. Methods Mol Biol. 2419:779. PubMed
  12. Wang Y, et al. 2021. Cancer Cell. :. PubMed
  13. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  14. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  15. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  16. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  17. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  18. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  19. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  20. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  21. Hofstee MI, et al. 2021. Eur Cell Mater. 41:774. PubMed
  22. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  23. Oba T, et al. 2021. J Immunother Cancer. 9:. PubMed
  24. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  25. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  26. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  27. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  28. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  29. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  30. Hu G, et al. 2021. Nat Commun. 12:773. PubMed
  31. Enders M, et al. 2020. J Immunol. 204:87. PubMed
  32. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  33. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  34. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  35. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  36. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  37. Majer O, et al. 2019. Nature. 575:366. PubMed
  38. Blriot C, et al. 2021. Immunity. :. PubMed
  39. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  40. Zander R, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.077. PubMed
  41. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  42. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  43. Ford J, et al. 2019. Front Immunol. 2.502083333. PubMed
  44. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  45. Karmaus PWF, et al. 2019. Nature. 565:101. PubMed
  46. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  47. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  48. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  49. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  50. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  51. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  52. Rogers P, Driessnack M, and Schwartz E. 2017. PLoS One. 10.1371/journal.pone.0181985. PubMed
  53. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  54. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  55. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  56. Zhang C, et al. 2020. Hear Res. 393:107996. PubMed
  57. Goltsev Y et al. 2018. Cell. 174(4):968-981 . PubMed
  58. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  59. Hofstee MI, et al. 2021. Pathogens. 10:. PubMed
  60. Jones GS, et al. 2020. mSphere. 5:. PubMed
  61. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  62. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  63. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  64. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  65. De Alessandris S, et al. 2019. J Leukoc Biol. 105:1183. PubMed
  66. Wichaiyo S, et al. 2019. Haematologica. 104:1648. PubMed
RRID
AB_1134213 (BioLegend Cat. No. 128001) AB_1134214 (BioLegend Cat. No. 128002)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线